ALGN icon

Align Technology

158.08 USD
-0.78
0.49%
At close Apr 1, 4:00 PM EDT
After hours
159.00
+0.92
0.58%
1 day
-0.49%
5 days
-6.41%
1 month
-9.72%
3 months
-24.18%
6 months
-35.57%
Year to date
-24.18%
1 year
-50.55%
5 years
0.56%
10 years
201.39%
 

About: Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Employees: 20,945

0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 7 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

0.39% more ownership

Funds ownership: 87.1% [Q3] → 87.5% (+0.39%) [Q4]

2% less first-time investments, than exits

New positions opened: 105 | Existing positions closed: 107

2% less funds holding

Funds holding: 716 [Q3] → 700 (-16) [Q4]

18% less capital invested

Capital invested by funds: $16.5B [Q3] → $13.6B (-$2.89B) [Q4]

23% less repeat investments, than reductions

Existing positions increased: 209 | Existing positions reduced: 273

43% less funds holding in top 10

Funds holding in top 10: 7 [Q3] → 4 (-3) [Q4]

48% less call options, than puts

Call options by funds: $163M | Put options by funds: $313M

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$235
49%
upside
Avg. target
$259
64%
upside
High target
$280
77%
upside

7 analyst ratings

positive
100%
neutral
0%
negative
0%
Mizuho
Steven Valiquette
29% 1-year accuracy
2 / 7 met price target
58%upside
$250
Outperform
Maintained
25 Mar 2025
Piper Sandler
Jason Bednar
32% 1-year accuracy
12 / 37 met price target
49%upside
$235
Overweight
Reiterated
18 Mar 2025
Wells Fargo
Vik Chopra
36% 1-year accuracy
4 / 11 met price target
61%upside
$255
Overweight
Initiated
14 Feb 2025
Evercore ISI Group
Elizabeth Anderson
48% 1-year accuracy
16 / 33 met price target
64%upside
$260
Outperform
Maintained
6 Feb 2025
Morgan Stanley
Erin Wright
56% 1-year accuracy
14 / 25 met price target
72%upside
$272
Overweight
Maintained
6 Feb 2025

Financial journalist opinion

Based on 10 articles about ALGN published over the past 30 days

Positive
Zacks Investment Research
6 hours ago
Is This the Right Time to Hold ALGN Stock in Your Portfolio?
Align Technology continues to attract investors' confidence thanks to its share gains in the malocclusion market and strategic deals.
Is This the Right Time to Hold ALGN Stock in Your Portfolio?
Neutral
Business Wire
7 hours ago
Align Technology to Announce First Quarter 2025 Results on April 30, 2025
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2025 financial results on Wednesday, April 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and wi.
Align Technology to Announce First Quarter 2025 Results on April 30, 2025
Neutral
Business Wire
1 week ago
Align Technology's Invisalign® Brand Announces Official Sponsorship of Bay FC
SAN FRANCISCO & SAN JOSE, Calif.--(BUSINESS WIRE)--Bay FC and Align Technology today announced that Align Technology's Invisalign® brand is an Official Partner of Bay FC.
Align Technology's Invisalign® Brand Announces Official Sponsorship of Bay FC
Positive
The Motley Fool
1 week ago
Align Technology: A Steady Leader in Dental Tech, but Is It Still a Buy?
Explore the exciting world of Align Technology (ALGN 1.11%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
Align Technology: A Steady Leader in Dental Tech, but Is It Still a Buy?
Positive
Zacks Investment Research
3 weeks ago
ALGN Stock to Benefit From the Launch of Align X-ray Insights Solution
Align Technologies unveils Align X-ray Insights, an AI-backed CADe solution.
ALGN Stock to Benefit From the Launch of Align X-ray Insights Solution
Neutral
Business Wire
3 weeks ago
Align Technology Launches Align X-ray Insights, an AI Computer-Aided Detection Software, in the European Union and United Kingdom
ROTKREUZ, Switzerland--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the launch in European Union countries and the United Kingdom of Align X-ray Insights, a new software-based (CADe*) computer aided detection solution that uses artifi.
Align Technology Launches Align X-ray Insights, an AI Computer-Aided Detection Software, in the European Union and United Kingdom
Negative
Zacks Investment Research
3 weeks ago
Why Is Align Technology (ALGN) Down 21.2% Since Last Earnings Report?
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?
Why Is Align Technology (ALGN) Down 21.2% Since Last Earnings Report?
Positive
Seeking Alpha
3 weeks ago
Align Technology: Brace Yourself, This Stock Is Undervalued
Align Technology is undervalued with a P/FCF multiple of 15x and WACC of 11.55%, despite strong market share and margin improvements. ALGN's Invisalign dominates over 90% of the clear aligners market, supported by high switching costs and premium pricing power. Financials show solid adjusted EBIT margins at 21.8%, with adjusted EPS on an upward trend, despite pandemic-related sales growth stagnation.
Align Technology: Brace Yourself, This Stock Is Undervalued
Positive
Zacks Investment Research
3 weeks ago
ALGN Stock Gains on Addition of Upgrades to the iTero Lumina Solutions
Align Technology adds restorative capabilities to the iTero Lumina Solutions - the iTero Lumina intraoral scanner and the iTero Lumina Pro dental imaging system.
ALGN Stock Gains on Addition of Upgrades to the iTero Lumina Solutions
Neutral
Business Wire
3 weeks ago
Align Technology Announces Availability of Restorative Capabilities on Its Next Generation iTero Lumina™ Intraoral Scanner and New iTero Lumina™ Pro Dental Imaging System
SAN JOSE, Calif. & TEMPE, Ariz. & PETACH TIKVA, Israel--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the addition of restorative capabilities to its next generation iTero Lumina™ intraoral scanner (without iTero Near Infra-Red Imaging (NIRI) tec.
Align Technology Announces Availability of Restorative Capabilities on Its Next Generation iTero Lumina™ Intraoral Scanner and New iTero Lumina™ Pro Dental Imaging System
Charts implemented using Lightweight Charts™